Johnson Matthey to spin off medical manufacturing arm for £550m
Chemicals specialist Johnson Matthey has spun off its Medical Device Components business to a private equity firm for over half a billion pounds. According to a notice from the firm…
Chemicals specialist Johnson Matthey has spun off its Medical Device Components business to a private equity firm for over half a billion pounds. According to a notice from the firm…
Lloyds Bank and Paypoint have announced they are expanding their existing partnership, with the lender set to become the main processor of card payments for Paypoint’s 60,000-strong network of small…
Investec Group published its pre-close trading update for the financial year to the end of March 2024, saying it expects double-digit earnings growth after a year of change. The trading…
Mike Ashley has stepped up his involvement in model trains brand Hornby after becoming a consultant to its chief executive. The billionaire majority owner of retail empire Frasers Group is…
Prudential has upped its dividend after reporting strong growth in new business over 2023, which the firm put down to its “relentless focus” on its new strategy. New business profit,…
Inflation fell faster than expected last month, raising questions for the Bank of England ahead of its latest interest rate decision. Figures from the Office for National Statistics (ONS) showed…
Is dismissing ideas about genuine reform of the tax system as “unfunded pledges” really the best the Labour leader can do? Asks Eliot Wilson Taxation runs through politics like a…
The corporate world’s obsession with meetings has gone too far, it’s time to imagine another way, says Simon Neville I hate meetings and in my previous life as a journalist,…
The Institute for Fiscal Studies’ claims that the policy will raise money do not take into account the unintended consequences – economic models rarely do, says James Price I often…
Kate’s doctored photo has plunged us into a trap where we question nothing because we’ve already dismissed it as fake. That’s where the truth goes to die, argues Andy Blackmore…